Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Lanuti, M.D.

Co-Author

This page shows the publications co-authored by Michael Lanuti and Jennifer Temel.
Connection Strength

0.588
  1. Effects of a perioperative geriatric intervention for older adults with Cancer: A randomized clinical trial. J Geriatr Oncol. 2022 Jan 21.
    View in: PubMed
    Score: 0.246
  2. Observations in lung cancer over multiple decades: an analysis of outcomes and cost at a single high-volume institution. Eur J Cardiothorac Surg. 2014 Aug; 46(2):254-61; discussion 261.
    View in: PubMed
    Score: 0.141
  3. Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):220.
    View in: PubMed
    Score: 0.044
  4. Integrating tobacco treatment into thoracic oncology settings: Lessons learned. J Health Psychol. 2016 12; 21(12):2813-2823.
    View in: PubMed
    Score: 0.039
  5. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol. 2011 Dec; 22(12):2616-2624.
    View in: PubMed
    Score: 0.030
  6. A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol. 2011 Jun; 6(6):1059-65.
    View in: PubMed
    Score: 0.029
  7. SNaPshot genotyping of non-small cell lung cancers (NSCLC) in clinical practice. J Clin Oncol. 2011 May 20; 29(15_suppl):7518.
    View in: PubMed
    Score: 0.029
  8. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011 Mar 23; 3(75):75ra26.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.